Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HMR1031

Known as: HMR 1031, HMR-1031 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Background Very late antigen‐4 (VLA4) plays a key role in the recruitment of eosinophils in allergic responses in animal studies. 
2004
2004
A pharmacoscintigraphic study was conducted to compare the dose deposition of HMR 1031 from the existing nebulizer formulation… Expand
2004
2004
BACKGROUND VLA-4 (Very late antigen 4, integrin alpha4beta1) plays an important role in cell-cell interactions that are critical… Expand
2004
2004
BACKGROUND Integrins such as VLA-4 (Very late antigen 4, integrin alpha4beta1) play key roles in cell-cell interactions that are… Expand
2003
2003
HMR1031 is a potent and specific antagonist of the integrin VLA‐4 (α4β1) binding to vascular cell adhesion molecule‐1 (VCAM‐1… Expand